|
JAMA |
Inhaled Pharmacotherapy for Stable COPD |
1 |
Yes |
6/23/2028 |
|
JAMA Internal Medicine |
New Frontier, New Challenges—Recognizing and Managing Adverse Effects of Antiamyloid Therapies |
1 |
Yes |
6/23/2028 |
|
JAMA Neurology |
Postvaccinal Meningoencephalitis With Radial Perivascular Enhancement |
1 |
Yes |
6/23/2028 |
|
JAMA Neurology |
T1-Weighted Spin Echo Sequence and Encephalitis |
1 |
Yes |
6/23/2028 |
|
American Medical Association |
Adapting to Patients' Needs - One ICU Pediatrician's Account |
0.5 |
Yes |
6/24/2028 |
|
American Medical Association |
AMA STEPSFORWARD - Mastering AI Governance - Key STEPS for Success |
0.25 |
Yes |
6/24/2028 |
|
AMA Journal of Ethics |
Ethics Talk: Illuminating the Science of Art |
0.5 |
Yes |
6/24/2028 |
|
AMA STEPS Forward |
Resident and Fellow Well-Being - Optimize Well-Being at Work for Physician Learners |
0.25 |
Yes |
6/24/2028 |
|
JAMA |
Screening for Intimate Partner Violence and Caregiver Abuse of Older or Vulnerable Adults - US Preventive Services Task Force Recommendation Statement |
1 |
Yes |
6/24/2028 |
|
JAMA |
Screening for Intimate Partner Violence and for Caregiver Abuse of Older or Vulnerable Adults - An Evidence Report and Systematic Review for the US Preventive Services Task Force |
1 |
Yes |
6/24/2028 |
|
JAMA Dermatology |
Evolution of Subacute Cutaneous Lupus Erythematosus |
1 |
Yes |
6/25/2028 |
|
JAMA |
Forearm Pain and Stiffness in a 34-Year-Old Woman |
1 |
Yes |
6/25/2028 |
|
JAMA Ophthalmology |
Intermittent Diplopia Following Resolution of Nasopharyngeal Carcinoma |
1 |
Yes |
6/26/2028 |
|
JAMA Otolaryngology – Head & Neck Surgery |
Patient With Hemoptysis and a Laryngeal Mass |
1 |
Yes |
6/26/2028 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Workplace Violence in Ambulatory Care |
1 |
Yes |
6/26/2028 |
|
JAMA Internal Medicine |
Continuous Glucose Monitor Use—Avoiding Overuse |
1 |
Yes |
6/30/2028 |
|
JAMA Internal Medicine |
Covariate-Constrained Randomization |
1 |
Yes |
6/30/2028 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Disclosure of Adverse Events: Part 1 |
0.75 |
Yes |
6/30/2028 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Disclosure of Adverse Events: Part 2 |
0 |
Yes |
6/30/2028 |
|
JAMA Internal Medicine |
Gender-Affirming Feminizing Hormone Therapy |
1 |
Yes |
6/30/2028 |
